Colorectal Cancer Molecular Diagnostics Global Market Report 2024

Description

Colorectal cancer, also known as colon cancer or rectal cancer, is a malignant tumor that forms in the colon (large intestine) or rectum (final part of the digestive tract before the anus). It originates from the inner lining of these gastrointestinal segments. Colorectal cancer molecular diagnostics involve advanced techniques to identify specific genetic mutations, alterations, and biomarkers crucial for understanding the development, progression, and treatment response of colorectal cancer.

The primary components of colorectal cancer molecular diagnostics include instruments, reagents, kits, and services. Instruments are specialized tools or devices designed for analyzing and detecting molecular changes, such as genetic mutations, variations in gene expression, or specific biomolecules, within biological samples from patients with colorectal cancer. Molecular diagnostic solutions employ technologies such as polymerase chain reaction (PCR), sequencing, mass spectrometry, transcription-mediated amplification, chips and microarrays, and isothermal nucleic acid amplification technology (INAAT). These diagnostics are utilized by various end-users, including hospitals, ambulatory surgical centers, diagnostic laboratories, and homecare settings.

The colorectal cancer molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer molecular diagnostics market statistics, including colorectal cancer molecular diagnostics industry global market size, regional shares, competitors with a colorectal cancer molecular diagnostics market share, detailed colorectal cancer molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer molecular diagnostics industry. This colorectal cancer molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer molecular diagnostics market size has grown strongly in recent years. It will grow from $2.35 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth observed in the historical period can be attributed to several factors, including the increasing incidence of colorectal cancer, heightened awareness and screening initiatives, a growing emphasis on personalized medicine, and government initiatives focused on cancer control. These factors collectively contributed to the expansion of colorectal cancer molecular diagnostics during the historic period.

The colorectal cancer molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.48 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The anticipated growth in the forecast period can be attributed to factors such as an aging population with increased risk factors for colorectal cancer, the integration of genomic data into clinical practices, the rise of precision medicine approaches, and global collaborative efforts in cancer research. Key trends expected in the forecast period encompass a growing emphasis on early detection biomarkers, the integration of artificial intelligence (AI) in data analysis, the prominence of circulating tumor DNA (ctDNA) analysis, the expansion of companion diagnostics for targeted therapies, and a heightened focus on immunotherapy biomarkers. These trends are poised to shape and drive the continued expansion of colorectal cancer molecular diagnostics in the forecasted period.

The anticipated surge in inflammatory bowel diseases (IBD) incidence is forecasted to be a significant driver propelling the growth of the colorectal cancer molecular diagnostic market. IBD comprises chronic gastrointestinal disorders marked by inflammation in the digestive tract, particularly impacting the colon and rectum. The increased prevalence of IBD necessitates accurate and advanced diagnostic solutions, crucial for determining systemic therapy for colorectal cancer (CRC). Molecular assessment of tumors heavily influences treatment decisions, driving demand for efficient diagnostic solutions. According to BioMed Central Ltd. in May 2021, IBD cases are expected to rise substantially, reaching around 69,000 in Iran, 220,000 in the Middle East, 2.2 million in India, and a notable 4.5 million in East Asia from 2020 to 2035. Hence, the escalating IBD incidences are poised to propel growth within the colorectal cancer molecular diagnostic market.

The escalating prevalence of colorectal cancer is forecasted to drive the growth of the colorectal cancer molecular diagnostics market. Colorectal cancer affects the colon or rectum, resulting from the uncontrolled growth of cells in these digestive system areas, leading to tumor formation. The upsurge in colorectal cancer cases intensifies the demand for molecular diagnostic tools crucial in cancer detection and treatment. As highlighted by the American Cancer Society in March 2023, an estimated 153,020 individuals are anticipated to receive a colorectal cancer diagnosis, with around 52,550 projected deaths. This forecast includes 19,550 cases and 3,750 deaths among individuals under 50 years old. Thus, the rising prevalence of colorectal cancer is a key driver fueling growth within the colorectal cancer molecular diagnostics market.

The reluctance of healthcare professionals to embrace advanced diagnostic technologies due to budget limitations and pricing pressures from leading product manufacturers is expected to pose a challenge, potentially restraining market growth. Despite the enhanced accuracy and efficiency offered by molecular diagnostic tools for colorectal cancer detection and monitoring, healthcare providers might be hesitant to invest in these costly technologies. For instance, as indicated by the National Health Service in February 2022, allocating $2.81 million (£2.3 billion) over three years to transform diagnostic services in England indicates the financial constraints faced. Consequently, this reluctance to adopt advanced diagnostic technologies due to financial limitations hampers the growth potential of the colorectal cancer molecular diagnostics market.

Major companies are dedicated to pioneering innovative solutions in molecular diagnostics and personalized medicine, exemplified by the introduction of the Shield Blood Test approach for early-stage colorectal cancer detection. Guardant Health, a prominent US-based biotechnology company specializing in oncology molecular diagnostic products, launched the Shield Blood Test in May 2022. This groundbreaking blood test offers a convenient screening method involving a simple blood draw, addressing challenges associated with patient reluctance to undergo screening. The test demonstrated a sensitivity of 91% for detecting colorectal cancer and 20% for identifying advanced adenomas, with a specificity of 92%. Leveraging data from diverse cohorts comprising over 2,000 individuals with colorectal cancer, 357 with advanced adenoma, and 3,757 healthy subjects, the Shield test identifies early signals of colorectal cancer in the blood.

In July 2023, New Day Diagnostics LLC, a reputable US-based medical equipment manufacturing company, completed the acquisition of Epigenomics AG assets for an undisclosed sum. This strategic acquisition broadens New Day Diagnostics' portfolio in the realm of cancer diagnostics by acquiring intellectual property from Epigenomics AG. Notably, the acquisition includes Epi ProColon, an innovative screening technology specifically designed for the non-invasive detection of colorectal cancer. Epigenomics AG, headquartered in Germany, is a recognized player in the field of colorectal cancer molecular diagnostics, emphasizing the development of cutting-edge technologies for cancer detection.

Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.

North America was the largest region in the colorectal cancer molecular diagnostics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the colorectal cancer molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The colorectal cancer molecular diagnostics market consists of revenues earned by entities by providing diagnostic genetic mutation analysis, biomarker profiling, and epigenetic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal cancer molecular diagnostics market consists of sales of molecular diagnostic biochips, liquid biopsy kits, and bioinformatics software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Molecular Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on colorectal cancer molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer molecular diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colorectal cancer molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Instruments; Reagents And Kits; Services
2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings
Companies Mentioned: Johnson & Johnson; Bayer AG; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13333

1. Executive Summary

2. Colorectal Cancer Molecular Diagnostics Market Characteristics

3. Colorectal Cancer Molecular Diagnostics Market Trends And Strategies

4. Colorectal Cancer Molecular Diagnostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Colorectal Cancer Molecular Diagnostics Market Size and Growth

5.1. Global Colorectal Cancer Molecular Diagnostics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Colorectal Cancer Molecular Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Colorectal Cancer Molecular Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Colorectal Cancer Molecular Diagnostics Market Segmentation

6.1. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Reagents And Kits
Services
6.2. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Polymerase Chain Reaction (PCR)
Sequencing
Mass Spectrometry
Transcription Mediated Amplification
Chips And Microarrays
Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
Homecare Settings

7. Colorectal Cancer Molecular Diagnostics Market Regional And Country Analysis

7.1. Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market

8.1. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Colorectal Cancer Molecular Diagnostics Market

9.1. China Colorectal Cancer Molecular Diagnostics Market Overview
9.2. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Colorectal Cancer Molecular Diagnostics Market

10.1. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Colorectal Cancer Molecular Diagnostics Market

11.1. Japan Colorectal Cancer Molecular Diagnostics Market Overview
11.2. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Colorectal Cancer Molecular Diagnostics Market

12.1. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Colorectal Cancer Molecular Diagnostics Market

13.1. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Colorectal Cancer Molecular Diagnostics Market

14.1. South Korea Colorectal Cancer Molecular Diagnostics Market Overview
14.2. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Colorectal Cancer Molecular Diagnostics Market

15.1. Western Europe Colorectal Cancer Molecular Diagnostics Market Overview
15.2. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Colorectal Cancer Molecular Diagnostics Market

16.1. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Colorectal Cancer Molecular Diagnostics Market

17.1. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Colorectal Cancer Molecular Diagnostics Market

18.5. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Colorectal Cancer Molecular Diagnostics Market

19.9. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Colorectal Cancer Molecular Diagnostics Market

20.13. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Colorectal Cancer Molecular Diagnostics Market

21.1. Eastern Europe Colorectal Cancer Molecular Diagnostics Market Overview
21.2. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Colorectal Cancer Molecular Diagnostics Market

22.1. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Colorectal Cancer Molecular Diagnostics Market

23.1. North America Colorectal Cancer Molecular Diagnostics Market Overview
23.2. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Colorectal Cancer Molecular Diagnostics Market

24.1. USA Colorectal Cancer Molecular Diagnostics Market Overview
24.2. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Colorectal Cancer Molecular Diagnostics Market

25.1. Canada Colorectal Cancer Molecular Diagnostics Market Overview
25.2. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Colorectal Cancer Molecular Diagnostics Market

26.1. South America Colorectal Cancer Molecular Diagnostics Market Overview
26.2. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Colorectal Cancer Molecular Diagnostics Market

27.1. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Colorectal Cancer Molecular Diagnostics Market

28.1. Middle East Colorectal Cancer Molecular Diagnostics Market Overview
28.2. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Colorectal Cancer Molecular Diagnostics Market

29.1. Africa Colorectal Cancer Molecular Diagnostics Market Overview
29.2. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape And Company Profiles

30.1. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape
30.2. Colorectal Cancer Molecular Diagnostics Market Company Profiles
- 30.2.1. Johnson & Johnson
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Bayer AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Danaher Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Becton Dickinson and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Colorectal Cancer Molecular Diagnostics Market Other Major And Innovative Companies

31.1. Biocartis Group NV
31.2. Agilent Technologies Inc.
31.3. Grifols S.A
31.4. Hologic Inc.
31.5. Biomerieux SA
31.6. Quidel Corporation
31.7. Bio-Rad Laboratories Inc.
31.8. Qiagen N.V.
31.9. Exact Sciences Corporation
31.10. Illumina Inc.
31.11. Cepheid
31.12. Myriad Genetics Inc.
31.13. Guardant Health
31.14. Luminex Corporation
31.15. GenMark Diagnostics

32. Global Colorectal Cancer Molecular Diagnostics Market Competitive Benchmarking

33. Global Colorectal Cancer Molecular Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Colorectal Cancer Molecular Diagnostics Market

35. Colorectal Cancer Molecular Diagnostics Market Future Outlook and Potential Analysis

35.1 Colorectal Cancer Molecular Diagnostics Market In 2028 - Countries Offering Most New Opportunities
35.2 Colorectal Cancer Molecular Diagnostics Market In 2028 - Segments Offering Most New Opportunities
35.3 Colorectal Cancer Molecular Diagnostics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer